A total of 88 human and 35 mouse samples showing either exhausted or non-exhausted traits were used to comprehensively uncover the molecular mechanisms of CD8+ T cell dysfunction and identify highly efficient targets for the treatment of cancer and chronic infections (Table 1). The gene discussed is CD8A; the disease is cancer.